课题基金 / 基金详情

Vaccine Renaissance Conference at the Institute for Immunology and Informatics

Vaccine Renaissance Conference at the Institute for Immunology and Informatics
免疫学和信息学研究所疫苗复兴会议
批准号:
8871668
负责人:
Anne Searls DeGroot
金额:
$0.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2019-06-30

项目摘要

项目成果

Anne Searls DeGroot的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):鉴于禽流感H7N9等新传染病的出现、被忽视的热带疾病的持续存在以及对生物恐怖主义的持续关注,疫苗研究人员必须有机会讨论疫苗学的最新进展,学习加快疫苗研究的新方法,并建立跨学科和跨机构的合作。疫苗复兴大会是由罗德岛大学免疫学和信息学研究所(ICued)主办的一次独特、高质量和独立资助的(非商业)疫苗会议,在过去十年的七次成功活动中,为国际、国家和地区的疫苗开发人员提供了一个分享他们的研究并建立跨学科合作的重要机会。疫苗复兴大会的主要目标是继续为讨论尖端疫苗研究提供一个独特的互动论坛,包括加速疫苗发现的新工具和技术。第二个目标是为学术研究人员、疫苗行业领袖和疫苗学学生提供一个讨论潜在合作的机会。与这些目标一致,会议包括侧重于生物防御、全球健康、新的疫苗方法、新的疫苗递送载体和佐剂以及与疫苗相关的尖端免疫学研究的内容。此外,会议的特色是在研究所实验室内举办的会议上进行免疫信息学和板凳技术方面的“动手”培训。为了扩大会议的影响范围,并使由此产生的讨论更容易获得,每年都会在备受好评的《人类疫苗和免疫疗法》杂志上发表一份年度会议纪要,其中包括与会者的综述和原创研究。到目前为止,已经举行了七次成功的、出席人数众多的会议,开辟了疫苗研究的新视角,同时也使包括许多妇女和少数族裔受训人员在内的广泛研究人员能够与知名疫苗接种专家互动。在目前的提案中,我们提议将这一独特、高度成功和互动的会议再延长五年,从2014年延长到2018年。
英文摘要
DESCRIPTION (provided by applicant): Given the emergence of novel infectious diseases such as avian influenza H7N9, the persistence of neglected tropical diseases and unremitting concerns about bio-terrorism, it is imperative for vaccine researchers to have the opportunity to discuss the latest advances in vaccinology, learn new methods to accelerate vaccine research, and establish inter-disciplinary and inter-institutional collaborations. The Vaccine Renaissance conference is a unique, high-quality and independently-funded (non-commercial) vaccine conference hosted by the Institute of Immunology and Informatics (iCubed) at the University of Rhode Island, and has provided international, national and regional vaccine developers with an important opportunity to share their research and establish interdisciplinary collaborations at seven successful events over the past decade. The primary objective of the Vaccine Renaissance Conference is to continue to provide a unique interactive forum for the discussion of cutting-edge vaccine research, including new tools and techniques for accelerating vaccine discovery. The secondary objective is to provide academic researchers, vaccine industry leaders and students of vaccinology with an opportunity to discuss potential collaborations. Consistent with these objectives, the conference includes content tracks focusing on biodefense, global health, novel vaccine approaches, new vaccine delivery vehicles and adjuvants, and cutting-edge vaccine-related immunology research. In addition, the conference features 'hands-on' training in immunoinformatics and bench-based techniques in sessions that are hosted within the laboratories of the Institute. To expand the reach of the conference and make the resulting discussions more accessible, an annual 'Proceedings' that features reviews and original research by the participants is published in the highly regarded journal Human Vaccines and Immunotherapeutics. Seven successful, well-attended conferences have taken place to date, opening new perspectives in vaccine research while also enabling a wide range of researchers including many women and minority trainees to interact with established vaccinologists. In the current proposal, we propose to extend this unique, highly successful and interactive conference for five more years, from 2014 through 2018.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISPRI-HCP: CHO protein impurity immunogenicity risk prediction for improving biosimilar product development and assessing product interchangeability
  • 批准号:
    10620080
  • 项目类别:
  • 资助金额:
    $200.0万
  • 财政年份:
    2022
  • 负责人:
    Anne Searls DeGroot
  • 依托单位:
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
  • 批准号:
    10216952
  • 项目类别:
  • 资助金额:
    $112.35万
  • 财政年份:
    2017
  • 负责人:
    Anne Searls DeGroot
  • 依托单位:
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
  • 批准号:
    9362529
  • 项目类别:
  • 资助金额:
    $122.12万
  • 财政年份:
    2017
  • 负责人:
    Anne Searls DeGroot
  • 依托单位:
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
  • 批准号:
    9978692
  • 项目类别:
  • 资助金额:
    $113.6万
  • 财政年份:
    2017
  • 负责人:
    Anne Searls DeGroot
  • 依托单位:
海外基金